Last deal
Amount
Stage
Date
all rounds
Total amount
date founded
Financing round
General
About Company
Industry
Sector :
Subsector :
Also Known As
founded date
founders
Number of employees
Company Type
Last funding type
IPO status
Contacts
location
Contact Email
Phone number
Website URL
Similar Companies1000
Sequence Bio
The company aims to improve drug target discovery and treatment of diseases.
Sector
Subsector
Location
total rounds
Rumi Scientific
Rumi Scientific uses human stem cell technology to discover fast-tracking drugs for genetic diseases.
Sector
Subsector
Keywords
Location
total rounds
total raised
Arrakis Therapeutics
Arrakis Therapeutics develops drugs to treat neurological disorders and other diseases using a drug discovery platform that targets RNA.
Sector
Subsector
Keywords
Location
total rounds
total raised
Methuselah Health
Methuselah Health discovers new ways to treat aging-related diseases.
Sector
Subsector
Keywords
Location
total rounds
Financials
Funding Rounds6
Number of Funding Rounds
Money Raised
Their latest funding was raised on 18.08.2017. Their latest round Series A
Y Combinator
Y Combinator is a startup fund and program that invests in a large number of startups twice a year.
Sector
Subsector
Location
total rounds
total raised
count Of Investments
count Of Exists
Slow Ventures
Slow Ventures is an early-stage venture capital firm.
Sector
Subsector
Keywords
Location
count Of Investments
count Of Exists
Co-Investors
Investors5
Number of lead investors
Number of investors
Travere Therapeutics
Travere Therapeutics develops life-changing therapies for rare diseases.
Sector
Subsector
Location
total rounds
total raised
count Of Investments
Techammer
Techammer is an angel investment firm that helps founders solve important problems.
Sector
Subsector
Location
count Of Investments
count Of Exists
Y Combinator
Y Combinator is a startup fund and program that invests in a large number of startups twice a year.
Sector
Subsector
Location
total rounds
total raised
count Of Investments
count Of Exists
People
Founders2
Ethan Oren Perlstein
Over the course of the last decade, first as a graduate student at Harvard University in the Department of Molecular and Cell Biology with PhD advisor Professor Stuart Schreiber and then as an independent postdoctoral fellow at the Lewis-Sigler Institute at Princeton University, Dr. Ethan Perlstein developed an approach to studying old drugs and discovering new drugs in model organisms called evolutionary pharmacology. Ethan is an author on 19 peer-reviewed scholarly publications, including the discovery of a novel mechanism of action for the antidepressant Zoloft based on studies in yeast cells.
current job
count Of Investments
Ethan Oren Perlstein
Henry Perlstein
Henry Perlstein is Software Engineer at Stony Point
current job
organization founded
Henry Perlstein
